{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:53:21Z","timestamp":1782269601684,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["221S034"],"award-info":[{"award-number":["221S034"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.etap.2023.104143","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T21:09:07Z","timestamp":1683148147000},"page":"104143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose\/kg-normalized norbuprenorphine values in individuals with opioid use disorder"],"prefix":"10.1016","volume":"100","author":[{"given":"Dilek","family":"Kaya-Aky\u00fczl\u00fc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"\u00d6zkan-Kotilo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Dan\u0131\u015fman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceylan","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beg\u00fcm","family":"O\u011fur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze Zengin","family":"\u0130spir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2023.104143_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10550887.2017.1361724","article-title":"Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population","volume":"36","author":"Albonaim","year":"2017","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.etap.2023.104143_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-5793(94)01129-X","article-title":"Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain","volume":"354","author":"Bare","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.etap.2023.104143_bib3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/ALN.0b013e318238fea0","article-title":"Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active","volume":"115","author":"Brown","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.etap.2023.104143_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5455\/bcp.20150404070711","article-title":"Reliability and Validity of the Turkish Version of the Clinical Opiate Withdrawal Scale (COWS)","volume":"25","author":"Canan","year":"2015","journal-title":"Bull. Clin. Psychopharmacol."},{"key":"10.1016\/j.etap.2023.104143_bib5","first-page":"303","article-title":"Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European American females","volume":"14","author":"Clarke","year":"2014","journal-title":"Pharm. J."},{"key":"10.1016\/j.etap.2023.104143_bib6","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/npp.2013.99","article-title":"An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans","volume":"38","author":"Crist","year":"2013","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.etap.2023.104143_bib7","first-page":"173","article-title":"A polymorphism in the OPRM1 3\u2032-untranslated region is associated with methadone efficacy in treating opioid dependence","volume":"18","author":"Crist","year":"2018","journal-title":"Pharm. J."},{"key":"10.1016\/j.etap.2023.104143_bib8","first-page":"260","article-title":"Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder","volume":"19","author":"Crist","year":"2019","journal-title":"Pharm. J."},{"key":"10.1016\/j.etap.2023.104143_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-244X-13-107","article-title":"Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population","volume":"13","author":"Ding","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.etap.2023.104143_bib10","first-page":"8","article-title":"Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach. Addict","volume":"6","author":"Ettienne","year":"2017","journal-title":"Behav. Rep."},{"key":"10.1016\/j.etap.2023.104143_bib11","first-page":"674","article-title":"Pharmacogenomics and Opioid Use Disorder: Clinical Decision Support in an African American Cohort","volume":"111","author":"Ettienne","year":"2019","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.etap.2023.104143_bib12","first-page":"70","article-title":"Reliability and validity of the Penn Alcohol Craving Scale (PACS) Revised Version for substance craving in male substance dependent inpatients","volume":"22","author":"Evren","year":"2011","journal-title":"Turk. J. Psychiatry"},{"key":"10.1016\/j.etap.2023.104143_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.forsciint.2018.04.038","article-title":"Toxicological investigation in blood samples from suspected impaired driving cases in the Milan area: Possible loss of evidence due to late blood sampling","volume":"288","author":"Ferrari","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.etap.2023.104143_bib14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00228-018-2548-8","article-title":"Voriconazole Greatly Increases the Exposure to Oral Buprenorphine","volume":"74","author":"Fihlman","year":"2018","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.etap.2023.104143_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta-and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.etap.2023.104143_bib16","unstructured":"Food and Drug Administation, 2002. Center for Drug Evaluation and Research."},{"key":"10.1016\/j.etap.2023.104143_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s004390000340","article-title":"Variant detection at the delta opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence","volume":"107","author":"Gelernter","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.etap.2023.104143_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1530-0277.2007.00339.x","article-title":"Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study","volume":"31","author":"Gelernter","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.etap.2023.104143_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.psychres.2013.11.001","article-title":"Association between gene variants and response to buprenorphine maintenance treatment","volume":"215","author":"Gerra","year":"2014","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.etap.2023.104143_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s12888-020-02843-2","article-title":"The Chinese version of obsessive compulsive drug use scale: validation in outpatient methadone maintenance treatment program","volume":"20","author":"Gong","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.etap.2023.104143_bib21","first-page":"3","article-title":"Reliability and validity of Beck Depression Inventory among university students","volume":"7","author":"Hisli","year":"1989","journal-title":"Turk. Psikol. Derg."},{"key":"10.1016\/j.etap.2023.104143_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2023.104143_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.5414\/CP203755","article-title":"The \u03bc-opioid receptor gene polymorphism 118A>G weakens the pharmacological action of buprenorphine","volume":"58","author":"Imai","year":"2020","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.etap.2023.104143_bib24","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1017\/S1461145712001137","article-title":"Association of the PDYN gene with alcohol dependence and propensity to drinl negative emontional states","volume":"16","author":"Karpyak","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.etap.2023.104143_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2022.103902","article-title":"Effects of UGT2B7 rs7662029 and rs7439366 polymorphisms on sublingual buprenorphine metabolism in heroin addicts: An improved PCR-RFLP assay for the detection of rs7662029 polymorphism","volume":"94","author":"Kaya-Aky\u00fczl\u00fc","year":"2022","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.etap.2023.104143_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2022.103979","article-title":"Sublingual buprenorphine\/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder","volume":"95","author":"Kaya-Aky\u00fczl\u00fc","year":"2022","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.etap.2023.104143_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ijnp\/pyaa069","article-title":"A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder","volume":"15","author":"Kranzler","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.etap.2023.104143_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9140","article-title":"Current status of opioid addiction treatment and related preclinical research","author":"Kreek","year":"2019","journal-title":"Sci. Adv. 5, eaax9140."},{"key":"10.1016\/j.etap.2023.104143_bib29","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0028-3908(87)90112-2","article-title":"Buprenorphine has potent kappa opioid receptor antagonist activity","volume":"26","author":"Leander","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.etap.2023.104143_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/cr.2009.33","article-title":"A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http:\/\/analysis.bio-x.cn)","volume":"19","author":"Li","year":"2009","journal-title":"Cell. Res."},{"key":"10.1016\/j.etap.2023.104143_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2023.104143_bib32","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00001756-199707280-00025","article-title":"Association between a delta opioid receptor gene polymorphism and heroin dependence in man","volume":"8","author":"Mayer","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.etap.2023.104143_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008877-200211000-00005","article-title":"Delta opioid antagonist efects of buprenorphine in rhesus monkeys","volume":"13","author":"Negus","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.etap.2023.104143_bib34","first-page":"263","article-title":"The development, validity, and reliability of the Addiction Profile Index (API)","volume":"23","author":"\u00d6gel","year":"2012","journal-title":"Turk. Psikiyatr. Derg."},{"key":"10.1016\/j.etap.2023.104143_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuroscience.2004.12.033","article-title":"Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene","volume":"133","author":"Pan","year":"2005","journal-title":"Oprm. Neurosci."},{"key":"10.1016\/j.etap.2023.104143_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2019.05.026","article-title":"Stress, craving and mood as predictors of early dropout from opioid agonist therapy","volume":"202","author":"Panlilio","year":"2019","journal-title":"Drug. Alcohol. Depend."},{"key":"10.1016\/j.etap.2023.104143_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cns.13138","article-title":"Association of opioid receptor gene polymorphisms with drinking severity and impulsivity related to alcohol use disorder in a Korean population","volume":"26","author":"Park","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.etap.2023.104143_bib38","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.bjp.0706686","article-title":"Delta opioid receptor ligands modulate anxiety-like behaviors in the rat","volume":"147","author":"Perrine","year":"2006","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.etap.2023.104143_bib39","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1007\/s12035-018-1253-z","article-title":"Alternative Splicing of the Delta-Opioid Receptor Gene Suggests Existence of New Functional Isoforms","volume":"56","author":"Piltonen","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.etap.2023.104143_bib40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/00952990.2020.1797064","article-title":"Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians","volume":"46","author":"Randesi","year":"2020","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"10.1016\/j.etap.2023.104143_bib41","first-page":"263","article-title":"A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder. J. Transl. Genet. Genom","volume":"4","author":"Segu\u00ed","year":"2020"},{"key":"10.1016\/j.etap.2023.104143_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.cr.7290272","article-title":"SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.etap.2023.104143_bib43","first-page":"361","article-title":"OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. Pharmagenomics","volume":"12","author":"Taqi","year":"2019","journal-title":"Pers. Med"},{"key":"10.1016\/j.etap.2023.104143_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0165-6147(93)90068-U","article-title":"Delta-Opioid receptor subtypes and cross-talk with mu-receptors","volume":"14","author":"Traynor","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.etap.2023.104143_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0166-2236(94)90110-4","article-title":"An opiate-receptor gene family Reunion","volume":"17","author":"Uhl","year":"1994","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.etap.2023.104143_bib46","first-page":"163","article-title":"Turkish version of the Beck Anxiety Inventory: psychometric properties","volume":"12","author":"Ulusoy","year":"1998","journal-title":"J. Cogn. Psychother."},{"key":"10.1016\/j.etap.2023.104143_bib47","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.etap.2023.104143_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0963689718811060","article-title":"Historical Review: Opiate Addiction and Opioid Receptors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transpl."},{"key":"10.1016\/j.etap.2023.104143_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/368979","article-title":"Pharmacogenomics and Opioid Analgesics: Clinical Implications","author":"Yiannakopoulou","year":"2015","journal-title":"Int. J. Genom."},{"key":"10.1016\/j.etap.2023.104143_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136364","article-title":"Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population","volume":"768","author":"Yuferov","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.etap.2023.104143_bib51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/jhg.2010.22","article-title":"Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region","volume":"55","author":"Zhang","year":"2010","journal-title":"J. Hum. Genet"},{"key":"10.1016\/j.etap.2023.104143_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1744-9081-2-28","article-title":"The mu-opioid receptor gene and smoking initiation and nicotine dependence","volume":"2","author":"Zhang","year":"2006","journal-title":"Behav. Brain Funct."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668923000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668923000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:58:39Z","timestamp":1761299919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668923000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":52,"alternative-id":["S1382668923000856"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2023.104143","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose\/kg-normalized norbuprenorphine values in individuals with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2023.104143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104143"}}